Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Vitesse Biologics

Vitesse Biologics
2015 FOUNDED
PRIVATE STATUS
Joint Venture LATEST DEAL TYPE
3 INVESTORS
Description

Developer of antibody and therapeutics intended to focus in the areas of immunology, hematology and oncology. The company's antibody and therapeutics are protein-based that helps to do enhance treatment, enabling physicians to deliver proper care to their patients.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • 400 Oyster Point Boulevard
  • Suite 202
  • South San Francisco, CA 94080
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Vitesse Biologics’s full profile, request a free trial.

Vitesse Biologics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Joint Venture 01-Jun-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Vitesse Biologics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Mayo Clinic Ventures Corporate Venture Capital Minority 000 0000 000000 0
Shire Corporation Minority 000 0000 000000 0
Velocity Pharmaceutical Development VC-Backed Company Minority 000 0000 000000 0

Vitesse Biologics Board Members (2)

Name Representing Role Since Contact
Info
Amanda Hayward Ph.D Self Board Observer 000 0000

1 Former Board Member

You’re viewing 1 of 2 board members. Get the full list »